BRAF and pleomorphic xanthoastrocytoma: Our data reveal that BRAF V600E mutations do represent a common hallmark in PXA while being absent in gcGBM and therefore are a helpful molecular (diagnostic) marker to differentiate PXA from gcGBM (p-value <0,001).